Conclusion Our study indicates that the use of the recently approved AOMs tirzepatide (Zepbound) and semaglutide (Wegovy) is associated with a significantly reduced risk of OSA among patients with obesity
This is backed up by another study on brain function, which found that creatine is most likely to exert an influence in situations whereby cognitive processes are stressed. A review suggested that creatine supplementation might also help the brain recover from trauma and shows promise for combating age-related cognitive decline
ab125066, Abcam), and SLC7A11 (1:200
This was shown in a study of more than 4,700 patients using GLP-1 agonist drugs compared to 654 patients using bupropion-naltrexone, a different type of medication used for managing obesity
Questions/inquiries can be sent to [email protected].
Stronger activation means more insulin secretion in response to food, slower gastric emptying, and greater appetite suppression